ПАРКИНСОН КАСАЛЛИГИ ВА ВАСКУЛЯР ПАРКИНСОНИЗМДА КОГНИТИВ ЎЗГАРИШЛАРНИНГ ГИПЕРКОРТИЗОЛЕМИЯ БИЛАН БОҒЛИҚЛИГИ

##article.authors##

  • Гульнора Саттаровна РАХИМБАЕВА
  • Дилшода Турдикуловна АКРАМОВА

##article.subject##:

Паркинсон касаллиги, васкуляр Паркинсонизм, Гиперкортизолемия, Кортизол гормони, когнитив бузилишлар, депрессия

##article.abstract##

Паркинсон касаллиги бугунги кун неврологияси ва гериатриясининг долзарб мавзуларидан бири хисобланади. Бугунги кунда ушбу касалликнинг этиологияси, патогенези  ва касаллик келтириб чиқараётган асоратлар хавфи чуқур ўрганилмоқда. . Клиник кузатувда жами 75 нафар бемор иштирок этди. Беморлар 3 гурухга бўлиб ўрганилди.биринчи гуруҳ паркинсон касаллиги бўлган беморлар, иккинчи гурух Васкуляр Паркинсонизм ташхиси бўлган беморлар, учинчи гуруҳ эса соғлом кўнгиллилар. Беморлардаги когнитив бузилишлар  Logical  Memory subtest  1 and 2, Wechsler Memory Scale Revised,   Hamilton Rating Scale for Depression Гамилтон шкаласисини қўллаган ҳолда ўрганилди.

Барча беморларда эрталабки қон зардобида кортизол гормонининг концентрацияси иммунофлюрессент усулида аниқланди. Нопараметрик усуллар лабаратор тахлил натижаларини ва  обьектив клиник маьлумотларни  статистик қайта ишлаш учун қўлланилди. Р нинг кахамиятлилик даражаси 0.05 га тенг бўлди.

 Паркинсон касаллиги ва Васкуляр Паркинсонизмда қон зардобида эрталабки кортизол концентрациясининг ўзгариши ва ривожланиб борувчи когнитив нуқсонлар орасида бевосита алоқалар мавжуд бўлиб, ушбу алоқалар бири бири билан узвий боғлиқ эканлиги аниқланди.

Библиографические ссылки

D. Akramova, G. Rakhimbaeva Hormonal pathogenetic effects and vascular-immunological aspects in secondary vascular parkinsonism

Parkinsonism & Related Disorders, Volume 46, Supplement 2, January 2018,

Page e61https://doi.org/10.1016/j.parkreldis.2017.11.206

A Hartmanna J .DVeldhuisbMDeuschleaHStandhardtaIHeuser, Twenty-Four Hour Cortisol Release Profiles in Patients With Alzheimer’s and Parkinson’s Disease Compared to Normal Controls: Ultradian Secretory Pulsatility and Diurnal Variation, Neurobiology of Aging, Volume 18, Issue 3, May–June 1997, Pages 285-289 https://doi.org/10.1016/S0197-4580(97)80309-0

P.Salmon C.Siwik W.Rebholz E.CashaI.LitvanbJ.V.FiloteobK.KayseraS.E.Sephtona, A dyadic Mbsr intervention for Parkinson’s disease patients/caregivers: Effects on distress, cortisol, and inflammation, Brain, Behavior, and Immunity

Volume 66, Supplement, November 2017, Pages e19-e20

https://doi.org/10.1016/j.bbi.2017.07.078

DavidSancho CantusaNataliaSantiesteban LópezaMaríaCuerda BallesteraSilviaSolera GómezbJosé Enriquede la Rubia Ortía

Revista Científica de la Sociedad Española de Enfermería Neurológica

Available online 6 December 2018 https://doi.org/10.1016/j.sedene.2018.09.002

Hemraj B.Dodiyaab Christopher B.ForsythbRobin M.VoigtbPhillip A.EngenbJinalPatelbMalihaShaikhbStefan J.GreencAnkurNaqibcAvikRoydJeffrey H.KordowerdKalipadaPahandKathleen M.ShannoneAliKeshavarzian, Neurobiology of Disease

December 2018https://doi.org/10.1016/j.nbd.2018.12.012

Vladimir S.KostićaDusicaLečićaMiroslavaDoderaJelenaMarinkovićbSašaFilipovića, Prolactin and cortisol responses to fenfluramine in Parkinson's disease

Biological Psychiatry

Volume 40, Issue 8, 15 October 1996, Pages 769-775

Aleksandar Videnovic, Diego Golombek

Circadian dysregulation in Parkinson's disease, Neurobiology of Sleep and Circadian Rhythms

Volume 2, January 2017, Pages 53-58

Xiaomei Zhong, Yuping Ning, Zhangying Wu, Cong Ouyang, A reliable global cognitive decline and cortisol as an associated risk factor for patients with late-life depression in the short term: A 1-year prospective study, Journal of Affective Disorders

Volume 240, November 2018, Pages 214-219https://doi.org/10.1016/j.jad.2018.07.052

Qijun Le, Jiabao Hu, Xiaohuan Cao, Siwen Kuang, Man Zhang … Transcriptomic and cortisol analysis reveals differences in stress alleviation by different methods of anesthesia in Crucian carp (Carassius auratus), Fish & Shellfish Immunology

Volume 84, January 2019, Pages 1170-1179

https://doi.org/10.1016/j.fsi.2018.10.061

R. Sathiyaa, T. Campbell, M.M. Vijayan Cortisol modulates HSP90 mRNA expression in primary cultures of trout hepatocytes

Comp. Biochem. Physiol. B Biochem. Mol. Biol., 129 (2001), pp. 679-685

Robert H. Pietrzak, Simon M. Laws, Yen Ying Lim, Sophie J. Bender Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer’s Disease: A 6-Year Prospective Cohort Study, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging

Volume 2, Issue 1, January 2017, Pages 45-52

https://doi.org/10.1016/j.bpsc.2016.08.006

Yoshinao Katsu, Taisen Iguchi, in Handbook of Hormones, 2016

Namni Goel, ... David F. Dinges, in Principles and Practice of Sleep Medicine (Fifth Edition), 2011

Bolitho, S.J., Naismith, S.L., Rajaratnam, S.M., et al., 2014. Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease. Sleep Med. 15 (3), 342–347

D.P. Breen, R. Vuono, U. Nawarathna, et al.Sleep and circadian rhythm regulation in early Parkinson disease 71 (5) (2014), pp. 589-595

N.A. Aziz, H. Pijl, M. Frolich, et al.Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson's disease

J. Neuroendocrinol., 23 (6) (2011), pp. 519-524

N.A. Aziz, H. Pijl, M. Flilich, et al.Leptin, adiponectin, and resistin secretion and diurnal rhythmicity are unaltered in Parkinson's disease

Mov. Disord., 26 (4) (2011), pp. 760-761

Загрузки

##submissions.published##

2021-06-22